Gwenn Hansen

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Daniel Burbach, as Attorney-in-Fact for Gwenn Hansen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gwenn Hansen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nurix Therapeutics, Inc. Chief Scientific Officer Restricted Stock Units 25,725 $702,464 $20.48 30 Jan 2026 Direct
Nurix Therapeutics, Inc. Chief Scientific Officer Common Stock 115,005 $96,604 $0.8400 03 Feb 2026 Direct
Nurix Therapeutics, Inc. Chief Scientific Officer Employee Stock Option (right to buy) 0 03 Feb 2026 Direct

Insider Reports Filed by Gwenn Hansen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NRIX Nurix Therapeutics, Inc. 03 Feb 2026 2 +$26,320 4 Chief Scientific Officer 03 Feb 2026, 21:12
NRIX Nurix Therapeutics, Inc. 30 Jan 2026 10 -$81,249 4 Chief Scientific Officer 30 Jan 2026, 20:36
NRIX Nurix Therapeutics, Inc. 30 Oct 2025 9 -$52,300 4 Chief Scientific Officer 30 Oct 2025, 18:01
NRIX Nurix Therapeutics, Inc. 14 Oct 2025 1 $0 4 Chief Scientific Officer 23 Oct 2025, 19:04
NRIX Nurix Therapeutics, Inc. 30 Jul 2025 9 -$51,743 4 Chief Scientific Officer 30 Jul 2025, 18:48
NRIX Nurix Therapeutics, Inc. 30 Apr 2025 7 -$38,841 4 Chief Scientific Officer 30 Apr 2025, 19:35
NRIX Nurix Therapeutics, Inc. 11 Feb 2025 2 $0 4 Chief Scientific Officer 13 Feb 2025, 16:11
NRIX Nurix Therapeutics, Inc. 30 Jan 2025 8 -$73,260 4 Chief Scientific Officer 30 Jan 2025, 19:48
NRIX Nurix Therapeutics, Inc. 30 Oct 2024 7 -$83,536 4 Chief Scientific Officer 30 Oct 2024, 20:30
NRIX Nurix Therapeutics, Inc. 30 Jul 2024 7 -$70,436 4 Chief Scientific Officer 30 Jul 2024, 19:06
NRIX Nurix Therapeutics, Inc. 30 Apr 2024 5 -$24,169 4 Chief Scientific Officer 30 Apr 2024, 18:33
NRIX Nurix Therapeutics, Inc. 13 Feb 2024 2 $0 4 Chief Scientific Officer 15 Feb 2024, 07:23
NRIX Nurix Therapeutics, Inc. 30 Jan 2024 5 -$18,649 4 Chief Scientific Officer 30 Jan 2024, 18:52
NRIX Nurix Therapeutics, Inc. 30 Oct 2023 5 -$8,487 4 Chief Scientific Officer 01 Nov 2023, 16:40
NRIX Nurix Therapeutics, Inc. 30 Jul 2023 5 -$18,189 4 Chief Scientific Officer 01 Aug 2023, 16:26
NRIX Nurix Therapeutics, Inc. 30 Apr 2023 3 -$11,219 4 Chief Scientific Officer 02 May 2023, 16:31
NRIX Nurix Therapeutics, Inc. 14 Feb 2023 2 $0 4 Chief Scientific Officer 15 Feb 2023, 15:10
NRIX Nurix Therapeutics, Inc. 30 Jan 2023 3 -$16,633 4 Chief Scientific Officer 01 Feb 2023, 15:15
NRIX Nurix Therapeutics, Inc. 30 Oct 2022 3 -$15,006 4 Chief Scientific Officer 01 Nov 2022, 19:33
NRIX Nurix Therapeutics, Inc. 09 Aug 2022 1 $0 4 Chief Scientific Officer 10 Aug 2022, 16:15
NRIX Nurix Therapeutics, Inc. 30 Jul 2022 3 -$18,585 4 Chief Scientific Officer 02 Aug 2022, 17:45
NRIX Nurix Therapeutics, Inc. 30 Apr 2022 3 -$12,902 4 Chief Scientific Officer 03 May 2022, 19:05
NRIX Nurix Therapeutics, Inc. 19 Jan 2022 2 $0 4 Chief Scientific Officer 21 Jan 2022, 15:14
NRIX Nurix Therapeutics, Inc. 03 Jan 2022 5 -$36,369 4 Chief Scientific Officer 04 Jan 2022, 15:19
NRIX Nurix Therapeutics, Inc. 01 Dec 2021 3 -$8,748 4 Chief Scientific Officer 02 Dec 2021, 16:43
NRIX Nurix Therapeutics, Inc. 01 Nov 2021 3 -$10,392 4 Chief Scientific Officer 02 Nov 2021, 17:28
NRIX Nurix Therapeutics, Inc. 27 Oct 2021 3 -$11,096 4 Chief Scientific Officer 28 Oct 2021, 19:23
NRIX Nurix Therapeutics, Inc. 01 Oct 2021 3 -$9,064 4 Chief Scientific Officer 04 Oct 2021, 17:16
NRIX Nurix Therapeutics, Inc. 07 Sep 2021 3 -$44,384 4 Chief Scientific Officer 08 Sep 2021, 17:08
NRIX Nurix Therapeutics, Inc. 01 Sep 2021 3 -$10,032 4 Chief Scientific Officer 02 Sep 2021, 16:22
NRIX Nurix Therapeutics, Inc. 02 Aug 2021 3 -$9,580 4 Chief Scientific Officer 03 Aug 2021, 17:39
NRIX Nurix Therapeutics, Inc. 01 Jul 2021 3 -$7,800 4 Chief Scientific Officer 02 Jul 2021, 16:03
NRIX Nurix Therapeutics, Inc. 01 Jun 2021 3 -$8,192 4 Chief Scientific Officer 02 Jun 2021, 16:49